Abstract
Transcatheter aortic valve replacement (TAVR) is a rapidly evolving procedure for the management of high-risk patients with severe aortic stenosis who require surgical intervention. Multidisciplinary specialty teams perform a rigorous selection process to optimally manage patients during this innovative procedure. With increasing experience, indications for TAVR are continuously expanding around the world, and the use in patients with aortic regurgitation and prior bioprosthetic aortic valves has been described. Alternative TAVR devices, procedural approaches, and various anesthetic approaches are emerging. While initially general anesthesia was employed, experience with TAVR under monitored anesthesia care is rapidly growing. Postoperatively, patients are typically monitored for procedure-specific complications in the ICU for the first 3 days. As different management techniques continue to develop, the decisions regarding anesthetic technique, monitoring, and postoperative care are based on specific patient selection and institutional experience.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
